MEFLOQUINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mefloquine Hydrochloride, and when can generic versions of Mefloquine Hydrochloride launch?
Mefloquine Hydrochloride is a drug marketed by Barr, Hikma, Hikma Intl Pharms, Sandoz, and Us Army Walter Reed. and is included in five NDAs.
The generic ingredient in MEFLOQUINE HYDROCHLORIDE is mefloquine hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mefloquine Hydrochloride
A generic version of MEFLOQUINE HYDROCHLORIDE was approved as mefloquine hydrochloride by BARR on December 29th, 2003.
Summary for MEFLOQUINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 145 |
| Clinical Trials: | 77 |
| Patent Applications: | 1,434 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MEFLOQUINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MEFLOQUINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Research and Innovation Agency of Indonesia | N/A |
| Universitas Padjadjaran | N/A |
| Prodia Diacro Laboratories P.T. | N/A |
Pharmacology for MEFLOQUINE HYDROCHLORIDE
| Drug Class | Antimalarial |
Medical Subject Heading (MeSH) Categories for MEFLOQUINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MEFLOQUINE HYDROCHLORIDE
US Patents and Regulatory Information for MEFLOQUINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | MEFLOQUINE HYDROCHLORIDE | mefloquine hydrochloride | TABLET;ORAL | 076392-001 | Dec 29, 2003 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz | MEFLOQUINE HYDROCHLORIDE | mefloquine hydrochloride | TABLET;ORAL | 076175-001 | Feb 20, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma | MEFLOQUINE HYDROCHLORIDE | mefloquine hydrochloride | TABLET;ORAL | 076523-001 | Oct 1, 2004 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hikma Intl Pharms | MEFLOQUINE HYDROCHLORIDE | mefloquine hydrochloride | TABLET;ORAL | 077699-001 | Apr 21, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
